In a story April 28 about ImmunoGen's third-quarter earnings, The Associated Press reported erroneously that ImmunoGen licensed trastuzumab emtansine to Roche. ImmunoGen licensed technology used in the drug to Roche. Full story
Scientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis (TB) and say the finding could lead swiftly to new treatments for the highly infectious disease. Full story
European regulators said on Friday they were relaxing curbs on the use of Roche's top-selling cancer drug Avastin to allow its use with Xeloda, another type of chemotherapy that is also made by Roche. Full story
For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney stones and pancreatic damage. Full story
NEW YORK (Reuters Health) - In another blow to diet drugs, Canadian researchers are reporting a link between Roche's Xenical and an increase in kidney injuries. Full story
By Ben Hirschler Full story
Roche is slashing its sales outlook for its blockbuster cancer medicine, with Severin Schwan, Roche CEO.
Health officials in Taiwan are on guard after on of its citizens contracted the deadly strain of bird flu while on a business trip in China. NBC’s Ian Williams reports.
